Related Experiment Video
Updated: Mar 25, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
miR-19a, -19b, and -26b Mediate CTGF Expression and Pulmonary Fibroblast Differentiation
Yen-Chou Chen1,2, Bing-Chang Chen3, Chung-Chi Yu1
1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Abstract:
Although microRNA (miRNA) dysregulation with intracellular signaling cascade disruption has been demonstrated in the pathophysiology of pulmonary fibrosis, the relationship between miRNAs and intracellular signaling cascades in pulmonary fibrosis remains unclear. Using the human embryonic lung fibroblast cell line WI-38, we observed endothelin-1 (ET-1)- and thrombin-induced expression of the differentiation markers α-smooth muscle actin (α-SMA) and vimentin along with increased connective tissue growth factor (CTGF) protein expression. Decreased CTGF protein expression by CTGF siRNA significantly blocked ET-1- and thrombin-induced α-SMA and vimentin expression in WI-38 cells. Activation of the mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinase ERK, c-Jun N-terminal kinase (JNK), and p38 contributed to ET-1- and thrombin-induced CTGF, α-SMA, and vimentin expression in WI-38 cells. TargetScan Human, miRanda, and PicTar prediction algorithms were used to predict miRNAs with binding sites in the 3' untranslated region (UTR) of CTGF mRNA. miR-19a, -19b, and -26b were candidate miRNAs of CTGF. Direct binding of the candidate miRNAs to the 3'-UTR of CTGF mRNA was verified through luciferase assay by using SV40-promoter-IRES-driven luciferase containing the 3'-UTR of CTGF mRNA as a reporter plasmid. ET-1 and thrombin reduced candidate miRNA levels. Candidate miRNA overexpression significantly suppressed ET-1- and thrombin-induced CTGF expression and reduced α-SMA and vimentin expression in the WI-38 cells. Furthermore, candidate miRNA levels were decreased in the lung tissues of mice with bleomycin-induced pulmonary fibrosis, and intratracheal application of miR-19a, -19b, and 26b reduced the pulmonary fibrotic severity induced by bleomycin. This study is the first to demonstrate crosstalk between MAPK activation and reduction in miR-19a, -19b, and -26b expression leading to lung fibroblast differentiation. J. Cell. Physiol. 231: 2236-2248, 2016. © 2016 Wiley Periodicals, Inc.
Insights
This study reveals that specific microRNAs (miRNAs) like miR-19a, -19b, and -26b are crucial in regulating lung fibroblast differentiation and mitigating pulmonary fibrosis. Their reduced expression, linked to MAPK activation, exacerbates fibrotic markers, while their restoration offers therapeutic potential.
Area of Science:
- Cell Biology
- Molecular Biology
- Pulmonary Medicine
Background:
- MicroRNA (miRNA) dysregulation is implicated in pulmonary fibrosis pathophysiology.
- The precise relationship between miRNAs and intracellular signaling cascades in this disease remains incompletely understood.
Purpose of the Study:
- To investigate the role of specific miRNAs in regulating lung fibroblast differentiation.
- To elucidate the connection between mitogen-activated protein kinases (MAPKs) and miRNA expression in the context of pulmonary fibrosis.
Main Methods:
- Utilized human embryonic lung fibroblast cell line (WI-38) and mouse models of bleomycin-induced pulmonary fibrosis.
- Assessed expression of differentiation markers (α-SMA, vimentin) and CTGF protein.
- Employed siRNA for CTGF knockdown and miRNA mimics for overexpression.
- Verified miRNA binding to CTGF mRNA 3'-UTR using luciferase assays.
- Analyzed MAPK pathway activation (ERK, JNK, p38).
Main Results:
- Endothelin-1 (ET-1) and thrombin induced fibroblast differentiation markers (α-SMA, vimentin) and CTGF expression.
- CTGF siRNA and MAPK activation contributed to this induction.
- miR-19a, -19b, and -26b were identified as direct regulators of CTGF.
- ET-1 and thrombin reduced levels of these miRNAs.
- Overexpression of these miRNAs suppressed ET-1/thrombin-induced differentiation markers.
- Levels of these miRNAs were decreased in fibrotic lung tissues of mice.
- Intratracheal delivery of these miRNAs attenuated bleomycin-induced pulmonary fibrosis.
Conclusions:
- Demonstrated crosstalk between MAPK activation and reduced miR-19a, -19b, and -26b expression in driving lung fibroblast differentiation.
- Identified miR-19a, -19b, and -26b as key suppressors of CTGF and subsequent fibrotic processes.
- Established the therapeutic potential of restoring these miRNAs in pulmonary fibrosis treatment.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Related Concept Videos
TGF - β Signaling Pathway
Introduction to Fibroblasts
Master Transcription Regulators